Safety of reconversion to calcineurin inhibitor (CNI) based immunosuppression in liver transplant recipients who had been converted to everolimus for post-transplant renal impairment
Küçük Resim Yok
Tarih
2018
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Lippincott Williams & Wilkins
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
[Abstract Not Available]
Açıklama
Joint International Congress of ILTS, ELITA and LICAGE -- MAY 23-26, 2018 -- Lisbon, PORTUGAL
WOS: 000436897700436
WOS: 000436897700436
Anahtar Kelimeler
Reconversion, Calcineurin, Immunosuppression, Recipients
Kaynak
Joint International Congress of ILTS, ELITA and LICAGE
WoS Q Değeri
Q1
Scopus Q Değeri
Cilt
102
Sayı
Supplement: 5
Künye
Dayangaç, M. (2018). Safety of reconversion to calcineurin inhibitor (CNI) based immunosuppression in liver transplant recipients who had been converted to everolimus for post-transplant renal impairment. Joint International Congress of ILTS, ELITA and LICAGE içinde (213-213. ss.). Lisbon, Portugal, 23-26 May 2018.
